Cancer Genetics and Epigenetics

Epigenetics deals with the study of heritable changes in gene, that does not include changes to the basic DNA arrangement — an adjustment in phenotype without an adjustment in genotype — which influences how cells read the genes.  The study of epigenetic modifications to the Cancer cells genome is called Cancer Epigenetics, that does not bring a change in the nucleotide sequence.

Risk expectation and prediction and Cancer prevention, growth counteractive action is also promising and encouraging areas of Epigenetics.

A high adequacy of demethylating agents were accounted for essentially in hematological malignancies in view of new conventions with low dose and long exposure, and their utilization is presently being striven for strong tumors.
During the cell’s transformation to Cancerous cell, Epigenetic modifications are also more important like genetic mutations. Their manipulation brings a great promising approach to for preventing, detecting and treatment of cancer

  • Heritable changes in gene
  • DNA arrangement
  • Nucleotide sequence

Related Conference of Cancer Genetics and Epigenetics

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Cancer Genetics and Epigenetics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in